Neem leaf glycoprotein directs T-bet-associated type 1 immune commitment

Area of Science:

• Immunology
• Natural Products Research

Background:

• Immune homeostasis is crucial for host defense.
• Immunosuppression compromises the immune system's ability to fight infections and cancer.
• Natural compounds are explored for their immunomodulatory potential.

Purpose of the Study:

• To investigate the immune activation and polarization effects of Neem leaf glycoprotein (NLGP).
• To determine NLGP's role in modulating T-helper (Th) cell responses and the innate immune microenvironment.
• To assess NLGP's potential in restoring immune balance in immunosuppressed states.

Main Methods:

• Flow cytometry was used to analyze immune cell activation markers (CD69, CD45RO, CD45RA, CD62L).
• Cytokine profiles (IFN-gamma, IL-4, IL-12, TNF-alpha, IL-10) were measured.
• Expression of transcription factors (T-bet, FoxP3) and STAT phosphorylation (STAT1, STAT4, STAT3) were assessed.

Main Results:

• NLGP upregulated CD69 on lymphocytes, monocytes, and dendritic cells, indicating activation.
• NLGP promoted a T-helper type 1 (Th1) immune response, evidenced by increased IFN-gamma and IL-12, and decreased IL-4 and IL-10.
• NLGP downregulated FoxP3(+) T-Reg cells and upregulated T-bet, STAT1, and STAT4 phosphorylation, favoring a type 1 immune environment.

Conclusions:

• NLGP effectively activates immune cells and promotes a type 1 immune polarization.
• NLGP may be beneficial in maintaining immune homeostasis in immunosuppressed hosts.
• The type 1 immune-promoting properties of NLGP suggest potential applications in host-protective antitumor immunity.